Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × HhAntag691 × Clear all

Sponsor

Conditions

Carcinoma, Basal Cell 14 Neoplasms 4 Pancreatic Neoplasms 3 Skin Neoplasms 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Medulloblastoma 2 Colorectal Neoplasms 2 Chondrosarcoma 2 Basal Cell Nevus Syndrome 2 Urinary Bladder Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Stomach Neoplasms 1 Solid Cancers 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma 1 Pancreatic Diseases 1 Osteosarcoma 1 Odontogenic Cysts 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Unknown Primary 1 Neoplasms, Basal Cell 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Myelodysplastic Syndromes 1

Interventions

vandetanib 7 Sorafenib 6 Magnetic Resonance Spectroscopy 6 lenvatinib 5 cabozantinib 5 Sunitinib 4 Iodine-131 4 selpercatinib 3 AZD 6244 3 trametinib 2 tipifarnib 2 durvalumab 2 dabrafenib 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Thyrotropin Alfa 2 Paclitaxel 2 Nivolumab 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Everolimus 2 Bortezomib 2 Axitinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 tremelimumab 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡